Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hirsh

Showing results (11-20 of 2,959) with videos related to

Pageof 296
Sort By:
Chest|December 12, 2003
Advances and contemporary issues in prophylaxis for deep vein thrombosisJack Hirsh
The New England Journal of Medicine|June 22, 1995
The optimal duration of anticoagulant therapy for venous thrombosisJ Hirsh
Texas Dental Journal|March 15, 2002
The journey of dentistry. My journey from practitioner to educatorM Hirsh
Thrombosis and Haemostasis|July 1, 1993
Low molecular weight heparinJ Hirsh
Canadian Medical Association Journal|February 17, 1973
PlateletsJ Hirsh
American Heart Journal|April 1, 1992
Antithrombotic therapy in deep vein thrombosis and pulmonary embolismJ Hirsh
Chest|January 1, 1999
Reversal of the anticoagulant effects of warfarin by vitamin K1J Hirsh
Archives of Internal Medicine|February 1, 1992
Substandard monitoring of warfarin in North America. Time for changeJ Hirsh
Archives of Internal Medicine|September 1, 1985
The optimal antithrombotic dose of aspirinJ Hirsh
The New England Journal of Medicine|May 30, 1991
HeparinJ Hirsh
Pageof 296

Showing results (11-20 of 2,959) with videos related to

Sort By:
Pageof 296
Chest|December 12, 2003
Advances and contemporary issues in prophylaxis for deep vein thrombosisJack Hirsh
The New England Journal of Medicine|June 22, 1995
The optimal duration of anticoagulant therapy for venous thrombosisJ Hirsh
Texas Dental Journal|March 15, 2002
The journey of dentistry. My journey from practitioner to educatorM Hirsh
Thrombosis and Haemostasis|July 1, 1993
Low molecular weight heparinJ Hirsh
Canadian Medical Association Journal|February 17, 1973
PlateletsJ Hirsh
American Heart Journal|April 1, 1992
Antithrombotic therapy in deep vein thrombosis and pulmonary embolismJ Hirsh
Chest|January 1, 1999
Reversal of the anticoagulant effects of warfarin by vitamin K1J Hirsh
Archives of Internal Medicine|February 1, 1992
Substandard monitoring of warfarin in North America. Time for changeJ Hirsh
Archives of Internal Medicine|September 1, 1985
The optimal antithrombotic dose of aspirinJ Hirsh
The New England Journal of Medicine|May 30, 1991
HeparinJ Hirsh
Pageof 296